CliffBio
small molecule

CHILDREN'S CLARITIN

LORATADINE

Loss of exclusivity—loss of exclusivity
CompanyBayer Healthcare →See this company's full patent-cliff portfolio

Drug detail

Brand nameCHILDREN'S CLARITIN
Active ingredientLORATADINE
Strength5MG
Dosage formTABLET, CHEWABLE
RouteORAL
ModalitySmall molecule
FDA approvalAugust 2006
Marketing statusOTC

More from Bayer Healthcare

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.